Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Therapeutic Expertise for Complex Clinical Development

When patient populations are small, endpoints are complex, or the regulatory path is unclear, the right data must lead to the right next decision.

Complex therapies bring distinct questions about study design, endpoints, recruitment, evidence, and the regulatory path.

For nearly 30 years, Veristat teams have helped biopharmaceutical companies turn those questions into data-driven direction, confident development decisions, and submission-ready evidence across oncology, rare disease, neurology, endocrine and metabolic disorders, inflammation and autoimmune disease, infectious disease, and more.

Patients cannot afford a development program built on generic assumptions.

Therapeutic depth matters when it changes the decision.

Knowing the science is important; knowing at what points the data, protocol, patient population, or regulatory strategy is likely to create risk is what helps a program move forward.

Whether you need integrated specialty CRO support, a focused service such as regulatory strategy, or experts to augment your team, Veristat brings experience that connects today's challenge to the evidence and decisions required next.

Our Core Therapeutic Areas

Nearly 30 years of experience means we've built real depth, not just breadth, across the therapeutic areas where sponsors need it most.

Oncology/Hematology.

Advancing novel treatments for solid tumors and hematologic malignancies with the scientific rigor these trials demand.

Learn More →

Neurology/Psychiatry.

Moving complex treatments for neurological disorders, pain management, and psychiatric conditions forward, faster.

Learn More →

Vaccines

From infectious disease outbreaks to oncology, our team brings hands-on clinical development experience across the vaccine landscape. Here's where that experience runs deepest.

Learn More →

Pediatric Complexity.

Veristat connects pediatric regulatory, clinical, biometrics, and medical experts before gaps put your program at risk.

Learn More →

Cell & Gene Therapies

Veristat has successfully supported more than 100 cell and gene therapy clinical trials and consulting projects in the past 5 years, with a global team of scientific experts adept at both strategy and execution across the clinical development journey.

Learn More →

Other Therapy Areas. 

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Scientific Thinking Across the Most Complex Product Types

Some of the toughest challenges in development aren't about disease area at all, they're about the therapy itself. Here's where our expertise runs deepest.

Rare Diseases.

Specialized experience navigating small, hard-to-reach patient populations and the unique regulatory pathways built for them.

Biologics.

Deep expertise across the added complexity biologics bring to development and manufacturing.

Vaccines.

Experience advancing vaccine candidates through trial design and regulatory review.

Cell & Gene Therapies.

Specialized support for the novel scientific and regulatory questions these advanced therapies raise.

~30

years

 

of experience bringing drugs, biologics, and diagnostics to market

Nearly every therapy area

represented across Veristat's project history

What's Next

Explore Your Path Forward

gradient green tones
Integrated Specialty CRO Support

Connect advisory, clinical operations, biometrics, regulatory strategy, and medical writing around the decision your program needs to support next.

Container-1-1
Rare Diseases

Specialized support for small, hard-to-reach patient populations.

Container-3-1
Decentralized Trials

Flexible trial models built around patient accessibility.

gradient green tones
Resourcing/FSP

Augment your in-house team with specific therapeutic or functional expertise.

Turn therapeutic expertise into direction.

When patients are waiting and the development path is complex, experience should do more than reassure you. It should help your team see risk earlier, generate decision-ready data, and choose the next step with confidence. Share where your program stands, and we'll follow up.

Frequently Asked Questions